A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy
口服 NF-κB 抑制剂 Flavocoxid 治疗杜氏肌营养不良症的 1/2 期研究
期刊:Brain Sciences
影响因子:2.7
doi:10.3390/brainsci11010115
Gian Luca Vita, Maria Sframeli, Norma Licata, Alessandra Bitto, Sara Romeo, Francesca Frisone, Annamaria Ciranni, Giovanni Pallio, Federica Mannino, M'Hammed Aguennouz, Carmelo Rodolico, Francesco Squadrito, Antonio Toscano, Sonia Messina, Giuseppe Vita